The skeletal dysplasias clinical-molecular correlations

Annals of the New York Academy of Sciences

Volumn 1117, Issue , 2007, Pages 302-309

  Rimoin, David L ^a   Cohn, Daniel ^a   Krakow, Deborah ^a   Wilcox, William ^a   Lachman, Ralph S ^a   Alanay, Yasemin ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Dwarf; Dysostosis; Dysplasia; Skeletal

Indexed keywords

SCLEROPROTEIN;

ACHONDROPLASIA; ACROCEPHALOSYNDACTYLY; ALBRIGHT SYNDROME; BONE ATROPHY; BONE DENSITY; BONE DYSPLASIA; BONE MALFORMATION; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE STRUCTURE; BRACHYDACTYLY; CHONDRODYSPLASIA; CHONDROPATHY; CLEIDOCRANIAL DYSPLASIA; CLINICAL EVALUATION; CONFERENCE PAPER; CORRELATION ANALYSIS; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DISEASE CLASSIFICATION; DYSCHONDROSTEOSIS; DYSOSTOSIS; ELLIS VAN CREVELD SYNDROME; EPIPHYSIS DISEASE; FIBROUS DYSPLASIA; GENETIC DISORDER; GENETIC HETEROGENEITY; HEREDITARY MULTIPLE EXOSTOSIS; HISTOPATHOLOGY; HUMAN; HYPOCHONDROPLASIA; HYPOPHOSPHATASIA; INFECTIOUS MONONUCLEOSIS; LARSEN SYNDROME; MARSHALL SYNDROME; MOLECULAR BIOLOGY; MORPHOLOGY; MUCOPOLYSACCHARIDOSIS; NAIL PATELLA SYNDROME; OSSIFICATION; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; OSTEOSCLEROSIS; PATIENT ASSESSMENT; RADIODIAGNOSIS; ROBINOW SYNDROME; SHORT STATURE; SPONDYLOEPIPHYSEAL DYSPLASIA; STICKLER SYNDROME; THANATOPHORIC DWARFISM; TURNER SYNDROME;

EID: 36549047040     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.072     Document Type: Conference Paper

References (19)

1. SPRANGER, J., P. BRILL & A. POZNANSKI. 2002. Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development, 2nd ed. Oxford University Press. New York.
2. UNGER, S., R.S. LACHMAN & D.L. RIMOIN. 2007. Chondrodysplasias. In Emery and Rimoin's Principles and Practice of Medical Genetics, 5th ed. Vol. 3. D.L. Rimoin, J.M. Connor, R.E. Pyeritz, et al., Eds.: 3709-3753. Elsevier. Philadelphia, PA.
3. SPRANGER, J. 1989. Radiologic nosology of bone dysplasias. Am. J. Med. Genet. 34: 96-104.
4. SUPERTI-FURGA, A. & S. UNGER. 2007. Nosology and classification of genetic skeletal disorders: 2006 revision. Am. J. Med. Genet. 143A: 1-18.
5. MORTIER, G.R. 2001. The diagnosis of skeletal dysplasias: a multidisciplinary approach. Eur. J. Radiol. 40: 161-167.
6. LACHMAN, R.S. 2007. Taybi and Lachman's Radiology of Syndromes, Metabolic Disorders and Skeletal Dysplasias, 5th ed. Elsevier. Philadelphia, PA.
7. ḦASTBACKA, J., A. DE LA CHAPELLE, M.M. MAHTANI, et al. 1994. The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by finestructure linkage disequilibrium mapping. Cell 78: 1073-1087.
8. SUPERTI-FURGA, A., A. ROSSI, B. STEINMANN, et al. 1996. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations. Am. J. Med. Genet. 63: 144-147.
9. ARIKAWA-HIRASAWA, E., W.R. WILCOX, A.H. LE, et al. 2001. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene. Nat. Genet. 27: 431-434.
10. KRAKOW, D., S.P. ROBERTSON, L.M. KING, et al. 2004. Mutations in the gene encoding filamin B disrupt vertebral segmentation, joint formation and skeletogenesis. Nat. Genet. 36: 405-410.
11. IKEGAWA, S. 2006. Genetic analysis of skeletal dysplasia: recent advances and perspectives in the post-genome-sequence era. J. Hum. Genet. 51: 581-586.
12. WILLIAMS, C.J. & D.J. PROCKOP. 1983. Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta. J. Biol. Chem. 258: 5915-5921.
13. MURRAY, L.W., J. BAUTAISTA, P.L. JAMES, et al. 1989. Type II collagen defects in the chondrodysplasias. I. Spondyloepiphyseal dysplasias. Am. J. Hum. Genet. 45: 5-15.
14. LEE, B., H. VISSING, F. RAMIREZ, et al. 1989. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science 244: 978-980.
15. SPRANGER, J., A. WINTERPACHT, B. ZABEL. 1994. The type II collagenopathies: a spectrum of chondrodysplasias. Eur. J. Pediatr. 153: 56-65.
16. HOORNAERT, K.P., C. DEWINTER, I. VEREECKE, et al. 2006. The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene. J. Med. Genet. 43: 406-413.
17. SUPERTI-FURGA, A., L. BONAFE & D. L. RIMOIN. 2001. Molecular-pathogenetic classification of genetic disorders of the skeleton. Am. J. Med. Genet. 106: 282-293.
18. RIMOIN, D., L.D. COHN & D. EYRE. 2004. Clinical-molecular correlations in the skeletal dysplasias. Pediatr. Radiol. 24: 425-426.
19. JAKKULA, E., O. MAKITIE, M. CZARNY- RATACJZAK, et al. 2005. Mutations in the known genes are not the major cause of MED; distinctive phenotypic entities among patients with no identified mutations. Eur. J. Hum. Genet. 13: 292-301.